ScholarIQanswers from OpenAlex
Korea Pharma (South Korea)
InstitutionResearch output, impact & collaborations
Korea Pharma (South Korea) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Korea Pharma (South Korea)?
ScholarIQrecord summary
Korea Pharma (South Korea) is a research organisation in Seoul, KR. OpenAlex records 1,265 works and 36,166 citations for it. 875 researchers list it as their most recent affiliation.
How many works does Korea Pharma (South Korea) have?
ScholarIQindexed works
Korea Pharma (South Korea) has 1,265 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Korea Pharma (South Korea) have?
ScholarIQcitation count
Korea Pharma (South Korea) has 36,166 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Korea Pharma (South Korea)?
ScholarIQresearcher count
Korea Pharma (South Korea) has 875 researchers in the ScholarIQ index.
What is the average h-index at Korea Pharma (South Korea)?
ScholarIQavg h-index
Korea Pharma (South Korea) has an average h-index of 108.5 in OpenAlex.
What is the ROR of Korea Pharma (South Korea)?
ScholarIQror
The ROR for Korea Pharma (South Korea) is on the source record.
What is the OpenAlex record for Korea Pharma (South Korea)?
ScholarIQopenalex
The OpenAlex for Korea Pharma (South Korea) is on the source record.
Who are the most-cited researchers behind Korea Pharma (South Korea)?
ScholarIQtop researchers by citations
What are the most-cited papers on Korea Pharma (South Korea)?
ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend, Wolfgang Köenig, Lawrence A. Leiter, Frederick J. Raal, Jenna A. Bisch, Tara Richardson, Mark Jaros, Peter Wijngaard, John J.P. Kastelein
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
John J.P. Kastelein, Fatima Akdim, Erik S.G. Stroes, Aeilko H. Zwinderman, Michiel L. Bots, Anton F. H. Stalenhoef, Frank L.J. Visseren, Eric J.G. Sijbrands, Mieke D. Trip, Evan A. Stein, Daniel Gaudet, Raphaël Duivenvoorden, Enrico P. Veltri, Adéle Marais, Eric de Groot
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, Kausik K. Ray, Denise Mason, John J.P. Kastelein, Paul D. Thompson, Peter Libby, Leslie Cho, Jorge Plutzky, Harold Bays, Patrick M. Moriarty, Venu Menon, Diederick E. Grobbee, Michael J. Louie, Chien‐Feng Chen, Na Li, LeAnne T. Bloedon, Paula Robinson, Maggie Horner, William J. Sasiela, Jackie McCluskey, Deborah Davey, Pedro Fajardo-Campos, Predrag Petrović, Ján Fedačko, Witold Żmuda, Yury Lukyanov, Stephen J. Nicholls
How much of the research on Korea Pharma (South Korea) is open access?
ScholarIQopen access share
78%OPEN ACCESS